Sally Beauty (NYSE:SBH – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Travere Therapeutics (TVTX – Research Report), with a ...

Fintel reports that on February 12, 2025, Canaccord Genuity upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) ...

Calvin Sandra, the Senior Vice President and Chief Accounting Officer at Travere Therapeutics, Inc. (NASDAQ:TVTX), executed a ...

Lyft’s ( NASDAQ: LYFT) Q4 results demonstrated its effective cost discipline, pricing dynamics, and consistent rider growth, ...

Coty posted quarterly earnings of 11 cents per share which missed the analyst consensus estimate of 21 cents per share. The ...

Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.

TD Bank Group is preparing for expansion in Canada following the sale of $20 billion worth of stock in The Charles Schwab ...

Canaccord Genuity analyst Alexander Bedwany reiterated a Sell rating on South32 Ltd. (S32 – Research Report) yesterday and set a price target ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Canaccord Genuity Group in a note issued to investors on Monday, MarketBeat reports.